Effects of seretide on lower airway bacterial colonization in stable phase of chronic obstructive pulmonary disease
10.3760/cma.j.issn.1671-7368.2012.09.012
- VernacularTitle:沙美特罗-替卡松吸入对慢性阻塞性肺疾病稳定期患者下呼吸道定植菌的影响
- Author:
Shunping HE
;
Zhifeng LIU
;
Dongmei LI
;
Jiang HUANG
- Publication Type:Journal Article
- Keywords:
Pulmonary disease,chronic obstructive;
Seretide;
Bacterial colonization
- From:
Chinese Journal of General Practitioners
2012;11(9):655-657
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effects of seretide (salmeterol 50 μg and fluticasone propionate 500 μg) on lower airway bacterial colonization (LABC) in the patients with stable moderate-tosevere chronic obstructive pulmonary disease (COPD).Methods A total of 84 patients with moderate-tosevere COPD were divided into 2 groups,i.e.test (n =43) and control (n =41).The control group received basic treatment while the test group seretide 50/500 μg per inhalation twice daily for 2 years plus basic treatment.Induced sputum specimens were analyzed for quantitative bacteriology and bacterial culture.The pulmonary function key parameters and exacerbation frequency were compared between two groups at pre- and post-therapy.Results The test group has significantly a lower positive rate of bacterial culture in the lower respiratory tract than before(16.3％ vs.34.9％,x2 =3.9091,P =0.0480).While in the control group,the positive rate of bacterial culture stayed almost the same as compared with that at pre-therapy (x2 =0.2253,P =0.6350).The test group had significantly decreased exacerbation frequency than the control group (1.9±2.1 vs.2.9 ±2.3,t =2.0364,P =0.0449);FEV1 of the control group decreased by (0.0885 ± 0.0186)L in 2 years and decreased by (0.0807 ± 0.0165)L in the test group.Significant differences existed in two groups (t =2.0355,P =0.0450).Conclusion The treatment of seretide can decrease LABC,slow decreasing trend of lung function and improve clinical symptoms in the patients with stable moderate-to-severe COPD.
